Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Explicit Inclusion of Diabetes Mellitus Without Retinopathy Within Diabetic Retinopathy Prediction.

Translational vision science & technology·2026

Same author

Multi-OCT-SelfNet: integrating self-supervised learning with multi-source data fusion for enhanced multi-class retinal disease classification.

Frontiers in systems biology·2026

Same author

Retinal imaging and artificial intelligence analysis.

Handbook of clinical neurology·2026

Same author

A Matching-Adjusted Comparison of Faricimab and Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.

Ophthalmic research·2026

Same author

Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

Journal of vitreoretinal diseases·2026

Same author

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE.

Ophthalmology science·2026

Same journal

Benchmarking and fine-tuning vision-language models on a visual question answering dataset for myopic maculopathy.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Same journal

Does lens opacity matter? The effect of cataract on deep learning based cardiovascular disease risk scores from fundus photos.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Same journal

Corrigendum to "Oculomics and AI: The eye as a biomarker for health span" [Asia-Pac J Ophthalmol 15 (1) (2026) 100282].

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Same journal

Visual preservation and surgical outcomes of phacogoniotomy in end-stage glaucoma: A multicenter study.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Same journal

Association of asymmetrical normal tension glaucoma, obstructive sleep apnoea and side sleeping.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

Same journal

Mechanism of myopic axial elongation related to Bruch´s membrane.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2026

查看所有相关文章

Search research articles

相关实验视频

Updated: May 12, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

人工智能用于视网膜疾病.

Jennifer I Lim¹, Aleksandra V Rachitskaya², Joelle A Hallak³

¹University of Illinois at Chicago, College of Medicine, Department of Ophthalmology and Visual Sciences, Chicago, IL, United States.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

|August 29, 2024

概括

此摘要是机器生成的。

人工智能 (AI) 在诊断和管理视网膜疾病,如糖尿病视网膜病变 (DR) 和与年龄相关的黄斑变性 (AMD) 中表现有前途. 人工智能可以预测疾病的进展,帮助治疗分析,可能减少失明.

关键词:

算法算法是一种算法.人工智能的人工智能是人工智能.生物标志物生物标志物深度学习是一种深度学习.查检查查检查查检查

更多相关视频

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

相关实验视频

Last Updated: May 12, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

科学领域:

眼科医生眼科眼科
医疗人工智能医疗人工智能
生物医学成像技术生物医学成像技术

背景情况:

在全球范围内,常见的视网膜疾病对视力构成重大威胁.
早期诊断和有效的管理对于预防视力丧失至关重要.

研究的目的:

审查人工智能 (AI) 在诊断和管理常见的视网膜疾病中的全球应用.
探索AI对治疗结果分析和疾病管理的潜在影响.

主要方法:

使用PubMed Central对视网膜疾病的AI应用进行了在线文献审查.
包括关于查,诊断,监测和治疗AMD,DR,ROP和SCR等疾病的结果的研究.
专注于AI与视网膜成像技术 (如OCT和OCTA) 的使用.

主要成果:

人工智能在查DR,AMD,ROP和SCR方面显示出有用性.
人工智能算法可以使用验证的数据集预测疾病进展和治疗反应.
人工智能可快速对来自OCT和OCTA的视网膜生物标志物进行定量分析,并可协助机器人手术规划.

结论:

人工智能工具可以帮助临床医生进行疾病查,监测和对治疗结果的定量分析.
人工智能可能有助于减少影响视网膜疾病结果的社会经济差异.
人工智能对预防视网膜疾病导致失明的公共卫生影响需要进一步确定.